GO:0005654 | nucleoplasm | 5.06e-04 | 1.00e+00 | 2.363 | 6 | 68 | 876 |
GO:0008380 | RNA splicing | 1.20e-03 | 1.00e+00 | 3.772 | 3 | 21 | 165 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0051028 | mRNA transport | 1.71e-03 | 1.00e+00 | 4.998 | 2 | 5 | 47 |
GO:0005643 | nuclear pore | 2.01e-03 | 1.00e+00 | 4.881 | 2 | 12 | 51 |
GO:0006684 | sphingomyelin metabolic process | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0000785 | chromatin | 2.68e-03 | 1.00e+00 | 4.670 | 2 | 6 | 59 |
GO:0030375 | thyroid hormone receptor coactivator activity | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0004767 | sphingomyelin phosphodiesterase activity | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0016363 | nuclear matrix | 4.08e-03 | 1.00e+00 | 4.363 | 2 | 10 | 73 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0003677 | DNA binding | 5.63e-03 | 1.00e+00 | 1.988 | 5 | 52 | 947 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 5 |
GO:0042382 | paraspeckles | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 3 | 5 |
GO:0002181 | cytoplasmic translation | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 3 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0005634 | nucleus | 8.61e-03 | 1.00e+00 | 1.058 | 9 | 158 | 3246 |
GO:0007617 | mating behavior | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 2 | 7 |
GO:2000273 | positive regulation of receptor activity | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0006878 | cellular copper ion homeostasis | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0051292 | nuclear pore complex assembly | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 4 | 8 |
GO:0031080 | nuclear pore outer ring | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 2 | 9 |
GO:0000398 | mRNA splicing, via spliceosome | 1.21e-02 | 1.00e+00 | 3.553 | 2 | 15 | 128 |
GO:0001967 | suckling behavior | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0001054 | RNA polymerase I activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0016409 | palmitoyltransferase activity | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 12 |
GO:0004527 | exonuclease activity | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 4 | 12 |
GO:0010906 | regulation of glucose metabolic process | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0008156 | negative regulation of DNA replication | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0016746 | transferase activity, transferring acyl groups | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0043393 | regulation of protein binding | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0016922 | ligand-dependent nuclear receptor binding | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 15 |
GO:0018345 | protein palmitoylation | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 15 |
GO:0070932 | histone H3 deacetylation | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 15 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.04e-02 | 1.00e+00 | 2.305 | 3 | 29 | 456 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 1 | 17 |
GO:0001227 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 2 | 17 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 18 |
GO:0035257 | nuclear hormone receptor binding | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 1 | 18 |
GO:0016573 | histone acetylation | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 19 |
GO:0006606 | protein import into nucleus | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 3 | 22 |
GO:0006687 | glycosphingolipid metabolic process | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 1 | 22 |
GO:0006281 | DNA repair | 2.89e-02 | 1.00e+00 | 2.888 | 2 | 24 | 203 |
GO:0002376 | immune system process | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 2 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 5 | 24 |
GO:0030901 | midbrain development | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 25 |
GO:0005902 | microvillus | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 1 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 3 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.54e-02 | 1.00e+00 | 4.798 | 1 | 4 | 27 |
GO:0050885 | neuromuscular process controlling balance | 3.67e-02 | 1.00e+00 | 4.746 | 1 | 1 | 28 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 6 | 29 |
GO:0042752 | regulation of circadian rhythm | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 5 | 29 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 3 | 30 |
GO:0004402 | histone acetyltransferase activity | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 3 | 30 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 6 | 31 |
GO:0000910 | cytokinesis | 4.31e-02 | 1.00e+00 | 4.509 | 1 | 2 | 33 |
GO:0050434 | positive regulation of viral transcription | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 5 | 35 |
GO:0006351 | transcription, DNA-templated | 4.65e-02 | 1.00e+00 | 1.482 | 4 | 47 | 1076 |
GO:0030900 | forebrain development | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 2 | 36 |
GO:0006665 | sphingolipid metabolic process | 4.95e-02 | 1.00e+00 | 4.305 | 1 | 1 | 38 |
GO:0048511 | rhythmic process | 4.95e-02 | 1.00e+00 | 4.305 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 6 | 40 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 5.45e-02 | 1.00e+00 | 4.161 | 1 | 4 | 42 |
GO:0008203 | cholesterol metabolic process | 6.08e-02 | 1.00e+00 | 3.998 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 6.08e-02 | 1.00e+00 | 3.998 | 1 | 1 | 47 |
GO:0032481 | positive regulation of type I interferon production | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 3 | 48 |
GO:0006355 | regulation of transcription, DNA-templated | 6.44e-02 | 1.00e+00 | 1.656 | 3 | 31 | 715 |
GO:0006310 | DNA recombination | 6.46e-02 | 1.00e+00 | 3.909 | 1 | 8 | 50 |
GO:0016020 | membrane | 6.65e-02 | 1.00e+00 | 1.316 | 4 | 56 | 1207 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.71e-02 | 1.00e+00 | 3.853 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 6.83e-02 | 1.00e+00 | 3.825 | 1 | 6 | 53 |
GO:0000777 | condensed chromosome kinetochore | 7.33e-02 | 1.00e+00 | 3.720 | 1 | 6 | 57 |
GO:0042826 | histone deacetylase binding | 7.46e-02 | 1.00e+00 | 3.695 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 5 | 61 |
GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding | 8.07e-02 | 1.00e+00 | 3.576 | 1 | 2 | 63 |
GO:0003676 | nucleic acid binding | 8.44e-02 | 1.00e+00 | 3.509 | 1 | 4 | 66 |
GO:0010951 | negative regulation of endopeptidase activity | 9.06e-02 | 1.00e+00 | 3.403 | 1 | 2 | 71 |
GO:0001649 | osteoblast differentiation | 9.42e-02 | 1.00e+00 | 3.344 | 1 | 5 | 74 |
GO:0030529 | ribonucleoprotein complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 5 | 82 |
GO:0003690 | double-stranded DNA binding | 1.05e-01 | 1.00e+00 | 3.178 | 1 | 6 | 83 |
GO:0044255 | cellular lipid metabolic process | 1.12e-01 | 1.00e+00 | 3.077 | 1 | 2 | 89 |
GO:0008201 | heparin binding | 1.15e-01 | 1.00e+00 | 3.045 | 1 | 4 | 91 |
GO:0006260 | DNA replication | 1.18e-01 | 1.00e+00 | 2.998 | 1 | 9 | 94 |
GO:0046983 | protein dimerization activity | 1.18e-01 | 1.00e+00 | 2.998 | 1 | 2 | 94 |
GO:0006397 | mRNA processing | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 12 | 110 |
GO:0010467 | gene expression | 1.57e-01 | 1.00e+00 | 1.490 | 2 | 49 | 535 |
GO:0031965 | nuclear membrane | 1.60e-01 | 1.00e+00 | 2.531 | 1 | 8 | 130 |
GO:0044212 | transcription regulatory region DNA binding | 1.75e-01 | 1.00e+00 | 2.393 | 1 | 13 | 143 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.79e-01 | 1.00e+00 | 1.368 | 2 | 22 | 582 |
GO:0004871 | signal transducer activity | 1.80e-01 | 1.00e+00 | 2.344 | 1 | 4 | 148 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.94e-01 | 1.00e+00 | 2.222 | 1 | 18 | 161 |
GO:0000166 | nucleotide binding | 2.11e-01 | 1.00e+00 | 2.094 | 1 | 13 | 176 |
GO:0003713 | transcription coactivator activity | 2.19e-01 | 1.00e+00 | 2.029 | 1 | 21 | 184 |
GO:0015031 | protein transport | 2.39e-01 | 1.00e+00 | 1.888 | 1 | 10 | 203 |
GO:0008134 | transcription factor binding | 2.45e-01 | 1.00e+00 | 1.846 | 1 | 10 | 209 |
GO:0030198 | extracellular matrix organization | 2.58e-01 | 1.00e+00 | 1.765 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 2.66e-01 | 1.00e+00 | 1.714 | 1 | 4 | 229 |
GO:0003723 | RNA binding | 2.83e-01 | 1.00e+00 | 1.605 | 1 | 22 | 247 |
GO:0003682 | chromatin binding | 2.88e-01 | 1.00e+00 | 1.576 | 1 | 15 | 252 |
GO:0044822 | poly(A) RNA binding | 2.88e-01 | 1.00e+00 | 0.911 | 2 | 45 | 799 |
GO:0043565 | sequence-specific DNA binding | 3.10e-01 | 1.00e+00 | 1.450 | 1 | 8 | 275 |
GO:0044281 | small molecule metabolic process | 3.11e-01 | 1.00e+00 | 0.832 | 2 | 35 | 844 |
GO:0008285 | negative regulation of cell proliferation | 3.12e-01 | 1.00e+00 | 1.439 | 1 | 11 | 277 |
GO:0009986 | cell surface | 3.25e-01 | 1.00e+00 | 1.368 | 1 | 5 | 291 |
GO:0016021 | integral component of membrane | 3.32e-01 | 1.00e+00 | 0.562 | 3 | 19 | 1526 |
GO:0000278 | mitotic cell cycle | 3.46e-01 | 1.00e+00 | 1.258 | 1 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.49e-01 | 1.00e+00 | 1.245 | 1 | 17 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.70e-01 | 1.00e+00 | 1.139 | 1 | 23 | 341 |
GO:0042802 | identical protein binding | 3.81e-01 | 1.00e+00 | 1.085 | 1 | 15 | 354 |
GO:0005794 | Golgi apparatus | 4.32e-01 | 1.00e+00 | 0.856 | 1 | 6 | 415 |
GO:0005886 | plasma membrane | 4.33e-01 | 1.00e+00 | 0.337 | 3 | 46 | 1784 |
GO:0005829 | cytosol | 4.35e-01 | 1.00e+00 | 0.335 | 3 | 88 | 1787 |
GO:0016032 | viral process | 4.42e-01 | 1.00e+00 | 0.811 | 1 | 30 | 428 |
GO:0045087 | innate immune response | 4.60e-01 | 1.00e+00 | 0.733 | 1 | 12 | 452 |
GO:0005730 | nucleolus | 4.95e-01 | 1.00e+00 | 0.304 | 2 | 74 | 1217 |
GO:0007165 | signal transduction | 5.73e-01 | 1.00e+00 | 0.282 | 1 | 24 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.88e-01 | 1.00e+00 | 0.222 | 1 | 29 | 644 |
GO:0008270 | zinc ion binding | 6.34e-01 | 1.00e+00 | 0.047 | 1 | 39 | 727 |
GO:0070062 | extracellular vesicular exosome | 6.69e-01 | 1.00e+00 | -0.127 | 2 | 51 | 1641 |
GO:0005515 | protein binding | 7.06e-01 | 1.00e+00 | -0.135 | 5 | 198 | 4124 |
GO:0005524 | ATP binding | 7.12e-01 | 1.00e+00 | -0.248 | 1 | 37 | 892 |
GO:0005737 | cytoplasm | 7.24e-01 | 1.00e+00 | -0.225 | 3 | 127 | 2633 |